KAVI-Institute of Clinical Research (KAVI-ICR) is proud to share insights from AfriBOP 2026, held from 16–20 March in Cape Town, which celebrated a decade of transformative impact in building Africa’s research capacity.

From 10–12 March 2026, researchers from KAVI-Institute of Clinical Research (KAVI-ICR) actively participated in the HIV Vaccine Science Academy held in Dar es Salaam, Tanzania. The academy, organized by the International AIDS Society, brought together early-career scientists and leading global experts to explore the latest advances in HIV vaccine research.

As the world marks World Tuberculosis Day on March 24th, KAVI-Institute of Clinical Research reaffirms its commitment to raising awareness, promoting early diagnosis, and supporting effective treatment of tuberculosis (TB). Tuberculosis remains one of the world’s deadliest infectious diseases, with millions of new cases reported annually. Despite progress, global reductions in TB incidence remain below targets, highlighting the urgent need for intensified action.